Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.
about
Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular PolypillA Metaanalysis of Interventions to Improve Adherence to Lipid-Lowering MedicationHealth system barriers and facilitators to medication adherence for the secondary prevention of cardiovascular disease: a systematic reviewFixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases.Innovative Approaches to Hypertension Control in Low- and Middle-Income Countries.The polypill approach - An innovative strategy to improve cardiovascular health in Europe.Do polypills lead to neglect of lifestyle risk factors? Findings from an individual participant data meta-analysis among 3140 patients at high risk of cardiovascular disease.Strengths and Limitations of Using the Polypill in Cardiovascular Prevention.Cognitive Impairment and Age-Related Vision Disorders: Their Possible Relationship and the Evaluation of the Use of Aspirin and Statins in a 65 Years-and-Over Sardinian PopulationInterventions to improve adherence to lipid-lowering medication.Cost-effectiveness and public health benefit of secondary cardiovascular disease prevention from improved adherence using a polypill in the UKThe Polypill: From Promise to Pragmatism.Management of hypertension and multiple risk factors to enhance cardiovascular health - a feasibility study in Singapore polyclinics.Process evaluation of the impact and acceptability of a polypill for prevention of cardiovascular disease.[Management of different cardiovascular risk factors with a combination tablet (polypill)].Stroke survivors', caregivers' and GPs' attitudes towards a polypill for the secondary prevention of stroke: a qualitative interview study.Hypercholesterolemia and Hypertension: Two Sides of the Same Coin.Tolerability of Antihypertensive Medications in Older Adults.Improving cardiovascular protection: focus on a cardiovascular polypill.Role of the polypill for secondary prevention in ischaemic heart disease.Usefulness of the Polypill for the Prevention of Cardiovascular Disease and Hypertension.Polypills for the prevention of Cardiovascular diseases.Triple Combination Therapy for Global Cardiovascular Risk: Atorvastatin, Perindopril, and Amlodipine.The power of two: an update on fixed-dose combinations for type 2 diabetes.The polypill: An effective approach to increasing adherence and reducing cardiovascular event risk.Eliciting patients' preferences for elastic compression stocking therapy after deep vein thrombosis: potential for improving compliance.Antiplatelet Efficacy of Fixed-Dose Aspirin-Clopidogrel Combination in Patients with Stable Coronary Artery Disease Treated with Drug-Eluting Stent Implantation.Optimal pharmacological treatment and adherence to medication in secondary prevention of cardiovascular events in Spain: Results from the CAPS study.Polypill-based therapy likely to reduce ethnic inequities in use of cardiovascular preventive medications: Findings from a pragmatic randomised controlled trial.Cost-effectiveness analysis of use of a polypill versus usual care or best practice for primary prevention in people at high risk of cardiovascular disease.A systematic review of adherence in Indigenous Australians: an opportunity to improve chronic condition management.Polypills for the secondary prevention of cardiovascular disease: effective in improving adherence but are they safe?Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: survey of studies published in The BMJ and PLOS Medicine.Impact of switching from different treatment regimens to a fixed-dose combination pill (polypill) in patients with cardiovascular disease or similarly high risk.Polypill treatments for cardiovascular diseases.Pharmacodynamic effects of a new fixed-dose clopidogrel-aspirin combination compared with separate administration of clopidogrel and aspirin in patients treated with coronary stents: The ACCEL-COMBO trial.Stroke Minimization through Additive Anti-atherosclerotic Agents in Routine Treatment (SMAART): study protocol for a randomized controlled trial.Role of ivabradine in management of stable angina in patients with different clinical profiles.
P2860
Q26753102-B4CA00FA-7391-4075-B3D2-12CCF32C0186Q28080044-FA75D455-593B-4A3F-947E-618622F6CA54Q28554270-4C44A102-99EB-4498-B3DF-EAF8F2E697A8Q30235416-8CEC69EA-5EDA-494E-BE4E-3AAEEA3DC139Q30240646-C5BD11D8-E2A7-44F7-BE77-892FF31040CAQ30398270-82E76E45-3C33-4DBB-AD61-D18EF8DE07F1Q31053249-EDB3CE15-82DA-4DEA-9D2E-E2DE891481E0Q33581084-5661D3D7-B030-410A-A050-29041B0F55B3Q34471418-19FC0BAF-4E92-4BC3-9ECF-FA0A5AC67E6EQ34547763-C2A448EF-CFCA-4D51-9158-3E9BE9BA0518Q35675611-BC292877-88A7-45B2-9CBC-066EBB00953DQ35742756-42A7BC05-C718-470A-A7B4-E34714A4550DQ36071553-3D66EC33-F3FC-4292-9A7E-C457ADB6AC98Q36120469-A08D0B82-8A3D-4321-9778-A5DB4E5C3909Q36322893-4BE44B2E-8979-46DC-BC67-C1195D400AB1Q36920006-82AC5162-3499-4C40-8646-B9413A564450Q38524257-BCAB508C-91D9-428C-A24D-B3E29D79D4A2Q38600758-2CC161DC-2C4C-43E7-8859-DDC4157EC840Q38664558-309909CE-7FBC-4D23-B9EC-82597CE86E78Q38670591-311AEA9B-0C76-483A-8CBD-45FB5FF1CC84Q38701607-29ED7557-D019-4889-812D-E5978EB7CE16Q38809466-8C60EB92-7BEB-4BDD-A644-A50DDA5CC44EQ38852188-31AC082C-DFDF-4A29-BCC6-2DE3F47FE28BQ38920983-36998D40-E421-4451-8D9D-27141C82F5EDQ39231217-A726CE46-183C-4CA9-9623-F7FFE054102FQ40209570-745D5EB2-229E-4B5C-89B3-7218BAA8F0C8Q40386250-8A8D0D33-FB2F-4E9F-B74F-8773CED75BD8Q40427749-8FBA39A4-60D4-4A9B-8FA9-75B2BBA76873Q40879488-D0E2996E-E347-4FA8-A792-208067B30007Q41617873-11103964-8A89-4EBA-8274-B589113B77C6Q47241656-0C2290F7-6C4D-4A27-8E63-951174F02EE0Q48129709-7239D747-4444-4F31-97FF-C76DCD386691Q50027688-16F42A1E-95FD-4DAE-A1BA-329E57782069Q50653704-805E08A7-D4F9-4462-9CEF-8547305A01C0Q50913648-B277010E-4639-4FF6-9FC9-4B7500A24DE2Q51185270-4F838EDA-51F0-466D-9D4A-A77A82F27811Q51740192-BD456C42-9815-4F9E-843B-E65CE017E730Q54961020-5B2565E5-C32A-4E81-BE3A-3C356870B5B9
P2860
Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Effect of fixed dose combinati ...... trolled trial in primary care.
@en
Effect of fixed dose combinati ...... trolled trial in primary care.
@nl
type
label
Effect of fixed dose combinati ...... trolled trial in primary care.
@en
Effect of fixed dose combinati ...... trolled trial in primary care.
@nl
prefLabel
Effect of fixed dose combinati ...... trolled trial in primary care.
@en
Effect of fixed dose combinati ...... trolled trial in primary care.
@nl
P2093
P50
P356
P1433
P1476
Effect of fixed dose combinati ...... trolled trial in primary care.
@en
P2093
Angela Wadham
Bruce Arroll
C Raina Elley
Dale Bramley
Linda Bryant
Natasha Rafter
Richard J Milne
Robert N Doughty
Varsha Parag
P356
10.1136/BMJ.G3318
P407
P577
2014-05-27T00:00:00Z